omniture

Research Reports for Top Traded Penny Stocks: Neostem, CEL-SCI & Advanced Cell Technology, More Reports for UnitedHealth, Crocs & Ciena

Pennystocksinsiders.com
2011-10-25 21:03 1325

VANCOUVER, British Columbia, October 25, 2011 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued Equity Research for top traded penny stocks: Neostem (AMEX:NBS), CEL-SCI (AMEX:CVM), Advanced Cell Technology (OTC: ACTC). More reports for UnitedHealth (NYSE:UNH), Crocs (NASDAQ:CROX) & Ciena (NASDAQ:CIEN).

Investors should not just focus on stock price or volume momentum when trading penny stocks; it is important to pay attention to see if there is any insider trading in the penny stocks companies before placing a buy order. Watch more tips on how to use insider trading data to make profitable trades here.

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Research Report Highlights:

Neostem Inc. (AMEX:NBS): CEO Granted Options Every 2 Weeks

Insider Trade Signals: NeoStem, Inc. (NeoStem) is an international biopharmaceutical company with global research and development capabilities and operations in three business units: U.S. adult stem cells, China adult stem cells and China pharmaceuticals, primarily antibiotics. PSI found company CEO, Robin Smith, granted options every two weeks. Want to know just how much better returns these insiders are seeing?

Read Full Report: http://www.Pennystocksinsiders.com/PR/102511B/NBS/Neostem.pdf

CEL-SCI Corporation (AMEX:CVM): Struggled Away 52-week Low Price for 2 Weeks

Insider Trade Signals: CEL-SCI Corporation announces the closing of its $4 million registered direct offering of common stocks and warrants on Oct 7. The losing streak may be stopped today. Want to track how the insiders' trading activities move forward?

Read Full Report: http://www.Pennystocksinsiders.com/PR/102511B/CVM/CEL-SCI.pdf

Advanced Cell Technology, Inc. (OTC: ACTC): CSO Sold His Shares

Insider Trade Signals: Shares in Advanced Cell Technology Inc. (OTC: ACTC) slid 11.89% to $0.10, with volume of 36.77 million shares traded. The biotechnology company last week said a recent European ruling may not impact stem cell lines derived from using the company's single-blastomere method. Want to know when insiders start selling? Get an email alert for the latest insider buying/selling by subscribing for free below.

Read Full Report: http://www.Pennystocksinsiders.com/PR/102511B/ACTC/AdvancedCellTechnology.pdf

Today Pennystocksinsiders.com also released other research reports for:

UnitedHealth Group Inc. (NYSE:UNH)
Read Full Report: http://www.Pennystocksinsiders.com/PR/102511B/UNH/UnitedHealth.pdf

Crocs, Inc. (NASDAQ:CROX)
Read Full Report: http://www.Pennystocksinsiders.com/PR/102511B/CROX/Crocs.pdf

Ciena Corporation (NASDAQ:CIEN)
Read Full Report: http://www.Pennystocksinsiders.com/PR/102511B/CIEN/Ciena.pdf

More Individual Stock Reports & Sector Reports:
http://www.Pennystocksinsiders.com/mediaroom/

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Pennystocksinsiders.com:

Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:
Please visit http://www.Pennystocksinsiders.com/disclaimers/index.php for details.

Source: Pennystocksinsiders.com
collection